Search - tctmd.com

Displaying 161 - 180 of 242

Sort: Relevancy | Date

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

Michael O'Riordan

November 12, 2018

News Daily News

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Michael O'Riordan

October 31, 2018

News Daily News

Big Fitness Equals Big Survival Benefit, New Study Shows

Michael O'Riordan

October 22, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Daily News

Beta-blocker Use in Pregnancy Doesn’t Up Birth Defect Risk, Study Suggests

Caitlin E. Cox

October 15, 2018

News Conference News TCT 2018

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Todd Neale

September 25, 2018

News Conference News ESC 2018

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Daily News

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

Michael O'Riordan

July 16, 2018

News Daily News

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Michael O'Riordan

June 18, 2018

News Daily News

Obesity Not Benign: Higher Risk of CVD Seen With Excess Weight

Michael O'Riordan

June 05, 2018

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

News Daily News

Hypertension During Pregnancy Linked With Subsequent A-fib in Women

Yael L. Maxwell

May 18, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Daily News

Uptick Seen in Medication Adherence Among Hypertensive Patients Using Mobile App

Michael O'Riordan

April 16, 2018

News Daily News

Prominent Investigator Takes Post at Medtronic as Pivotal Renal Denervation Trial Is Announced

Todd Neale

April 12, 2018

News Daily News

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Michael O'Riordan

April 09, 2018

News Conference News ACC 2018

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

Michael O'Riordan

March 15, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

Advertisement

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Big Fitness Equals Big Survival Benefit, New Study Shows

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Beta-blocker Use in Pregnancy Doesn’t Up Birth Defect Risk, Study Suggests

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Obesity Not Benign: Higher Risk of CVD Seen With Excess Weight

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Hypertension During Pregnancy Linked With Subsequent A-fib in Women

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Uptick Seen in Medication Adherence Among Hypertensive Patients Using Mobile App

Prominent Investigator Takes Post at Medtronic as Pivotal Renal Denervation Trial Is Announced

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content